For research and educational purposes only. Not medical advice.
Octreotide Reference
Educational, not medical advice reference for Octreotide: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also known as San…
Reference summary
Octreotide is a label-verified somatostatin analog with decades of approved-label endocrine-oncology evidence. pepSmart surfaces label-reference content only.
- Categories
- Hormonal
- Aliases
- Sandostatin, Sandostatin LAR, Somatostatin analog
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication. Labeled uses include acromegaly, carcinoid-syndrome symptoms, and VIPoma-related watery diarrhea. Immediate-release (Sandostatin) and long-acting depot (Sandostatin LAR) are separate label products.
- Content review status
- label verified